CD274 and breast cancer: Further multi–omics studies depicted distinct predictive or prognostic biomarkers for prognosis, programmed death ligand 1 (PD-L1) expression, response to chemotherapy and immunotherapy, immune escape of BC, and immune infiltrates (115–119).